Tscan Therapeutics Inc (TCRX)

$8.98 0.08 (0.90%)

16:00 EDT TCRX Stock Quote Delayed 30 Minutes

TCRX Stock Earnings: TScan Therapeutics Misses EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings May 13, 2024

TCRX stock results show that TScan Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With

TCRX Stock Earnings: TScan Therapeutics Beats EPS, Beats Revenue for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 177,730

Day's Range $8.74 - $9.01

52-Week Range $1.93 - $9.36

Dividend & Yield N/A (N/A)

TCRX Stock Predictions, Articles, and Tscan Therapeutics Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer May 30, 2023

It's time for a look at the biggest pre-market stock movers on Tuesday morning with all the details traders need to know about!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer May 26, 2023

It's time for another dive into the biggest pre-market stock movers as we check out what's happening this morning on Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jan 24, 2023

We're starting the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!

TScan Therapeutics appoints CFO (NASDAQ:TCRX)

From Seeking Alpha Jan 29, 2024

TScan Therapeutics appointed Jason Amello as CFO. Amello joins from Candel Therapeutics

TScan Therapeutics director discloses purchase of 29,147 shares (NASDAQ:TCRX)

From Seeking Alpha Dec 22, 2023

TScan Therapeutics director purchases over $140K worth of shares in a recent insider trade, indicating confidence in the company's prospects.

TScan Therapeutics gets new technology chief (NASDAQ:TCRX)

From Seeking Alpha Dec 4, 2023

TScan Therapeutics appoints Justin McCue, Ph.D., as its new CTO.

TScan Therapeutics CFO resigns (NASDAQ:TCRX)

From Seeking Alpha Jun 29, 2023

TScan Therapeutics (TCRX) CFO Brian M. Silver, J.D., will be leaving the Company, effective July 21, 2023, to pursue a new opportunity at a leading advisory firm based in New...

TScan Therapeutics stock slides on pricing $140M securities offering (NASDAQ:TCRX)

From Seeking Alpha May 26, 2023

TScan Therapeutics (TCRX) is down 8.23% after-hours on Thursday after the firm has priced an underwritten public offering of 22.99M shares of its common stock at a public offering price...

H.C. Wainwright Sticks to Its Buy Rating for TScan Therapeutics (TCRX)

From TipRanks Nov 15, 2022

H.C. Wainwright analyst Andrew Fein maintained a Buy rating on TScan Therapeutics (TCRX – Research Report) today and set a price target of $15.00. The company...

ADVERTISEMENT